Bulbar Palsy, Progressive
"Bulbar Palsy, Progressive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A motor neuron disease marked by progressive weakness of the muscles innervated by cranial nerves of the lower brain stem. Clinical manifestations include dysarthria, dysphagia, facial weakness, tongue weakness, and fasciculations of the tongue and facial muscles. The adult form of the disease is marked initially by bulbar weakness which progresses to involve motor neurons throughout the neuroaxis. Eventually this condition may become indistinguishable from AMYOTROPHIC LATERAL SCLEROSIS. Fazio-Londe syndrome is an inherited form of this illness which occurs in children and young adults. (Adams et al., Principles of Neurology, 6th ed, p1091; Brain 1992 Dec;115(Pt 6):1889-1900)
Descriptor ID |
D010244
|
MeSH Number(s) |
C10.574.562.300 C10.668.467.300
|
Concept/Terms |
Bulbar Palsy, Progressive- Bulbar Palsy, Progressive
- Bulbar Palsies, Progressive
- Palsies, Progressive Bulbar
- Palsy, Progressive Bulbar
- Progressive Bulbar Palsies
- Progressive Bulbar Palsy
Bulbar Palsy- Bulbar Palsy
- Bulbar Palsies
- Palsies, Bulbar
- Palsy, Bulbar
- Paralysis, Bulbar
- Bulbar Paralyses
- Bulbar Paralysis
|
Below are MeSH descriptors whose meaning is more general than "Bulbar Palsy, Progressive".
Below are MeSH descriptors whose meaning is more specific than "Bulbar Palsy, Progressive".
This graph shows the total number of publications written about "Bulbar Palsy, Progressive" by people in this website by year, and whether "Bulbar Palsy, Progressive" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2013 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bulbar Palsy, Progressive" by people in Profiles.
-
Hematologic presentation and the role of untargeted metabolomics analysis in monitoring treatment for riboflavin transporter deficiency. Am J Med Genet A. 2020 11; 182(11):2781-2787.
-
Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2. Brain. 2014 Jan; 137(Pt 1):44-56.